Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAMI Methoxyflurane as Analgesic in Prehospital STEMI
2025-523349-86-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in myocardial infarction (MI) comparing Methoxyflurane (Penthrox) inhalation with Morphine (2 arms). Primary endpoint: Pain relief at 30 minutes. Planned start Feb 2026; status: authorised.
02
Drugs
methoxyfluranemorphine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2025-523349-86-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523349-86-00.